ZYTIGA® (abiraterone acetate)

LET’S DO THIS WITH

ZYTIGA® FIRST

(ABIRATERONE ACETATE)

ZYTIGA® (abiraterone acetate) in combination with prednisone is now indicated for the treatment of patients with metastatic high-risk castration-sensitive prostate cancer (CSPC).

VIEW THE OFFICIAL PRESS RELEASE